PMC:7311890 / 19378-19528
Annnotations
LitCovid-PD-MONDO
Id | Subject | Object | Predicate | Lexical cue | mondo_id |
---|---|---|---|---|---|
T101 | 108-116 | Disease | denotes | COVID-19 | http://purl.obolibrary.org/obo/MONDO_0100096 |
LitCovid-PD-CHEBI
Id | Subject | Object | Predicate | Lexical cue | chebi_id |
---|---|---|---|---|---|
T193 | 32-50 | Chemical | denotes | palmitoylcarnitine | http://purl.obolibrary.org/obo/CHEBI_73067 |
T194 | 52-69 | Chemical | denotes | stearoylcarnitine | http://purl.obolibrary.org/obo/CHEBI_73074 |
T195 | 75-90 | Chemical | denotes | oleoylcarnitine | http://purl.obolibrary.org/obo/CHEBI_72689 |
T196 | 125-127 | Chemical | denotes | S3 | http://purl.obolibrary.org/obo/CHEBI_29388 |
LitCovid-PubTator
Id | Subject | Object | Predicate | Lexical cue | tao:has_database_id |
---|---|---|---|---|---|
531 | 8-22 | Chemical | denotes | acylcarnitines | MESH:C116917 |
532 | 32-50 | Chemical | denotes | palmitoylcarnitine | MESH:D010172 |
533 | 52-69 | Chemical | denotes | stearoylcarnitine | |
534 | 75-90 | Chemical | denotes | oleoylcarnitine | MESH:C026968 |
554 | 108-116 | Disease | denotes | COVID-19 | MESH:C000657245 |
LitCovid-sentences
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T134 | 0-150 | Sentence | denotes | Several acylcarnitines, such as palmitoylcarnitine, stearoylcarnitine, and oleoylcarnitine, were reduced in COVID-19 (Figure S3, β-oxidation pathway). |
LitCovid-PMC-OGER-BB
Id | Subject | Object | Predicate | Lexical cue |
---|---|---|---|---|
T398 | 8-22 | CHEBI:17387;CHEBI:17387 | denotes | acylcarnitines |
T399 | 32-50 | CHEBI:15525;CHEBI:15525 | denotes | palmitoylcarnitine |
T400 | 52-69 | CHEBI:15541;CHEBI:15541 | denotes | stearoylcarnitine |
T401 | 75-90 | CHEBI:30823;CHEBI:30823 | denotes | oleoylcarnitine |
T402 | 108-116 | SP_7 | denotes | COVID-19 |
T403 | 130-131 | GO:0006635 | denotes | - |
T404 | 131-140 | GO:0006635;MOP:0000568 | denotes | oxidation |
T298 | 60-65 | GO:0016265 | denotes | carni |